Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.
The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.
We provide sector-specific support in a number of business areas historically linked to Regimbeau.
Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.
For each type of company, Regimbeau provides tailor-made support, in line with its realities.
Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.
The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.
We provide sector-specific support in a number of business areas historically linked to Regimbeau.
Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.
For each type of company, Regimbeau provides tailor-made support, in line with its realities.
We are thrilled to announce that Regimbeau has been recognized in the @Financial Times Ranking – 2024 edition! The Financial Times in collaboration with the research institute Statista has published…
By etWho’s Who Legal has announced the results of its 2024 review of leading patent & trademark attorneys in France. Regimbeau is pleased to announce the recognition of Jean-Robert Callon de…
By etWe are thrilled to announce that Regimbeau has been recognized in the IAM Patent 1000 – 2024 edition in the “silver – firms prosecution” category! This esteemed IAM ranking highlights the…
By etMedtech companies are at the forefront of innovation for patient health. However, as compared to other technical fields, medtech involves specific IP challenges that need to be well understood to…
By etFrédérique Durieux, Partner at Regimbeau and representative before the UPC, has been interviewed by Options Droit et Affaires, a specialized legal and financial news magazine for legal and business professionals. …
By etWe are pleased to announce that Regimbeau received an award as Europe Cross-Border Patent Litigation Team of the Year from Managing IP for its work on the Bristol-Myers Squibb (Apixaban)…
By etThe latest data from the European Patent Office (EPO) for the year 2023 is now available, revealing some interesting trends in technological innovation. In 2023, three sectors stood out…
By etRegimbeau has once again been ranked “Leading” and “Excellent” by Décideurs Magazine in its 2024 rankings of French IP law firms. Regimbeau is particularly distinguished by its ranking as “Leading”…
By etJuve Patent, a reference platform specialized in the European patent market, has recently published its annual ranking of the best patent practitioners in Europe for 2024. This year, Regimbeau has…
By etRegimbeau is thrilled to announce an EPI webinar led by Sylvain Thivillier, a seasoned expert in patent litigation, on March 20th, from 10:00 AM to 11:00 AM. This webinar entitled…
By etAll European patent attorneys of Regimbeau are now registered to act before the Unified Patent Court, forming a team of almost 40 UPC Representatives covering all technical fields. Regimbeau’s patent…
By etJérôme Collin will be part of the FICPI leadership team who will meet the President and the leadership team of the EPO in Munich on October,17. As FICPI Special Reporter…
By etThis website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
More information about our Cookie Policy
